Japanese Journal of Clinical Immunology
Online ISSN : 1349-7413
Print ISSN : 0911-4300
ISSN-L : 0911-4300
Original Article
The role of CD4+CD25+ regulatory T cells in patients with Rheumatoid Arthritis
Rumi MINAMIKouko SAKAITomoya MIYAMURAMasahiro YAMAMOTOEiichi SUEMATSU
Author information
JOURNAL FREE ACCESS

2006 Volume 29 Issue 1 Pages 37-42

Details
Abstract
  CD4+CD25+ regulatory T cells play an important role in preventing autoimmunity. We investigated the presence of CD4+CD25+ regulatory T cells in the peripheral blood of patients with rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), and systemic sclerosis (SSc), using flow cytometry. The percentage of CD4+CD25+ regulatory T cells was significantly decreased in RA, especially in patients with high serum levels of either CRP or MMP-3. In SSc and SLE, the percentage of CD4+CD25+ regulatory T cells was higher in patients than in controls, but not significant. We also investigated the serum levels of IL-10, which influences the function of CD4+CD25+ regulatory T cells and other regulatory T cells. In RA, on contrast to CD4+CD25+ regulatory T cells, the serum levels of IL-10 increased in patients with higher serum levels of CRP, or MMP-3. In SLE and SSc, the serum level of IL-10 increased significantly in patients than in controls. These data thus indicated that CD4+CD25+ regulatory T cells contributes to occurrence and progression of RA, and other regulatory T cells or cytokines contribute to occurrence and progression of SSc and SLE.
Content from these authors
© 2006 The Japan Society for Clinical Immunology
Previous article Next article
feedback
Top